September 26, 2024 by University of Glasgow An ingredient that can be added to food to make it more filling may be less effective at preventing weight gain in young people but could help them build more muscle, new research suggests. In a new paper published in eClinicalMedicine, researchers from U.K. universities report on the...
Tag: <span>obesity</span>
Post
Study shows bariatric surgery outperforms GLP-1 diabetes drugs for kidney protection
September 20, 2024 by Cleveland Clinic Credit: Pixabay/CC0 Public DomainA Cleveland Clinic study showed that in patients with type 2 diabetes, obesity, and chronic kidney disease, bariatric surgery was associated with a significant decrease in the progression of chronic kidney disease compared to those who received GLP-1 diabetes medications. The paper was published in Annals...
Post
Cellular sludge around hunger neurons linked to worsening diabetes and obesity
By Pooja Toshniwal PahariaReviewed by Danielle Ellis, B.Sc. Researchers uncover how the buildup of extracellular matrix proteins and sugars prevents insulin from reaching hunger-regulating neurons, leading to disrupted metabolism and increased risk of obesity. Study: Pathogenic hypothalamic extracellular matrix promotes metabolic disease. Image Credit: Love Employee/Shutterstock.comIn a recent study published in Nature, researchers reveal a...
Post
‘Remarkable’ Weight Loss Seen With Novel Oral Combination That Is Safe and Tolerable in Phase 1 Study
Medscape Medical News > Conference News > EASD 2024 Becky McCall September 12, 2024 MADRID — Amycretin, a dual pathway, oral weight loss drug, led to up to 13% body weight loss in participants with overweight or obesity according to phase 1, first-in-human study data presented at the European Association for the Study of Diabetes...
Post
Breaking the link between obesity and atrial fibrillation with a new cellular target
News Release 4-Sep-2024 Peer-Reviewed PublicationUniversity of Illinois Chicago A cellular link between obesity and atrial fibrillation — a heart condition that afflicts over 33 million people worldwide — presents a promising target for new therapies, researchers from the University of Illinois Chicago report. Obesity is among the leading causes of atrial fibrillation, an irregular heart...
Post
Diabetes and obesity can cause liver failure—but few people know their risk of developing liver disease
JULY 22, 2024 by Madona Azar, The Conversation Credit: Unsplash/CC0 Public DomainLiver disease is frighteningly common worldwide. Metabolic dysfunction-associated steatotic liver disease, or MASLD, is an umbrella term describing conditions related to a buildup of fat in the liver. Formerly known as nonalcoholic fatty liver disease, this condition affects 1 in 4 people worldwide. Among...
Post
Should South Park: The End of Obesity Be Required Viewing in Medical School?
Medscape Diabetes & Endocrinology > Expounding on ObesityCOMMENTARY Yoni Freedhoff, MD DISCLOSURES | June 28, 2024 Yes, there’s still much to find offensive, but South Park: The End of Obesity, in just 51 minutes, does more to explain some of obesity’s realities, its pharmacotherapy, and weight bias than the mainstream media has done perhaps ever....
Post
Severe obesity in childhood can halve life expectancy, global modeling study finds
MAY 14, 2024 by European Association for the Study of Obesity Credit: Unsplash/CC0 Public Domain New research being presented at the European Congress on Obesity (ECO) in Venice, Italy (12-15 May) has for the first time quantified the impact of different aspects of childhood obesity on long-term health and life expectancy. The modeling by stradoo...
Post
India left waiting another year for Wegovy
Novo Nordisk is ”very enagaged” in India, the CFO says, but the weight-loss drug will not be launched there until 2025. Photo: Tom Little BY CHRISTIAN BUNDGAARD28 May 2024at 09:50 People with obesity in India will have to wait to get access to Novo Nordisk’s big seller Wegovy, according to the local Indian media Business...
Post
Weight Loss Drug Tested in Mice May Be More Effective Than Existing Medicines
Promising new therapy for obesity that leads to greater weight loss in mice than existing medications. NewsPublished: May 17, 2024 | Original story from the University of Copenhagen Credit: Diana Polekhina / Unsplash. “I consider the drugs available on the marked today as the first generation of weight-loss drugs. Now we have developed a new...